大博医疗
(002901)
| 流通市值：118.27亿 | | | 总市值：169.75亿 |
| 流通股本：2.88亿 | | | 总股本：4.14亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 641,496,893.47 | 2,600,859,747.67 | 1,876,254,824.66 | 1,210,439,721.5 |
| 营业收入 | 641,496,893.47 | 2,600,859,747.67 | 1,876,254,824.66 | 1,210,439,721.5 |
| 二、营业总成本 | 460,125,572.77 | 1,948,789,556.99 | 1,409,952,460.92 | 905,711,853.76 |
| 营业成本 | 165,746,915.26 | 767,186,046.77 | 539,806,274.28 | 350,949,246.66 |
| 税金及附加 | 9,888,765.37 | 36,479,100.35 | 26,554,607.37 | 16,917,941.8 |
| 销售费用 | 171,440,269.24 | 692,354,067 | 503,760,426.79 | 323,088,306.04 |
| 管理费用 | 33,358,556.56 | 152,398,199.63 | 113,460,049.02 | 79,024,266.31 |
| 研发费用 | 78,888,340.64 | 331,197,614.5 | 250,245,754.07 | 159,780,959.47 |
| 财务费用 | 802,725.7 | -30,825,471.26 | -23,874,650.61 | -24,048,866.52 |
| 其中:利息费用 | 1,306,232.03 | 6,176,130.6 | 4,904,153.66 | 3,913,617.22 |
| 其中:利息收入 | 7,193,347.21 | 27,486,848.7 | 20,314,304.32 | 13,622,536.69 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 10,594,554.75 | 49,413,965.8 | 37,714,385.71 | 8,123,863.38 |
| 加:投资收益 | 479,554.97 | 4,720,096.25 | 5,808,707.64 | 1,696,330.72 |
| 资产处置收益 | 6,459.83 | 622,992.64 | 77,132.18 | 81,389.27 |
| 资产减值损失(新) | -15,297,890.63 | -64,855,384.85 | -45,966,819.41 | -35,330,627.97 |
| 信用减值损失(新) | 1,039,682.21 | -2,149,393.05 | 2,974,442.76 | 4,059,815.99 |
| 其他收益 | 6,461,374.84 | 97,821,165.82 | 47,448,522.36 | 15,306,433.48 |
| 四、营业利润 | 184,655,056.67 | 737,643,633.29 | 514,358,734.98 | 298,665,072.61 |
| 加:营业外收入 | 114,133.7 | 1,131,435.55 | 659,769.65 | 481,455.7 |
| 减:营业外支出 | 434,516.49 | 8,730,838.92 | 674,157.41 | 408,265.77 |
| 五、利润总额 | 184,334,673.88 | 730,044,229.92 | 514,344,347.22 | 298,738,262.54 |
| 减:所得税费用 | 22,444,370 | 93,165,497.8 | 65,520,677.92 | 39,499,238 |
| 六、净利润 | 161,890,303.88 | 636,878,732.12 | 448,823,669.3 | 259,239,024.54 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 161,890,303.88 | 636,835,173.88 | 448,823,669.3 | 259,239,024.54 |
| 终止经营净利润 | - | 43,558.24 | - | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 146,565,626.19 | 599,631,709.82 | 424,646,236.99 | 244,258,762.4 |
| 少数股东损益 | 15,324,677.69 | 37,247,022.3 | 24,177,432.31 | 14,980,262.14 |
| 扣除非经常损益后的净利润 | 131,999,195.79 | 479,640,950.33 | 345,970,933.43 | 222,695,524.72 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.36 | 1.47 | 1.04 | 0.6 |
| (二)稀释每股收益 | 0.36 | 1.47 | 1.04 | 0.6 |
| 八、其他综合收益 | -708,649.52 | 57,287.36 | 385,712.63 | 465,507.78 |
| 归属于母公司股东的其他综合收益 | -523,403.58 | 151,481.72 | 285,174.35 | 330,218.55 |
| 九、综合收益总额 | 161,181,654.36 | 636,936,019.48 | 449,209,381.93 | 259,704,532.32 |
| 归属于母公司股东的综合收益总额 | 146,042,222.61 | 599,783,191.54 | 424,931,411.34 | 244,588,980.95 |
| 归属于少数股东的综合收益总额 | 15,139,431.75 | 37,152,827.94 | 24,277,970.59 | 15,115,551.37 |
| 公告日期 | 2026-04-30 | 2026-04-24 | 2025-10-29 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |